OcuTerra Therapeutics, Inc. — Form D
OcuTerra Therapeutics, Inc. of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2023-12-22. The offering totals $30.0M, of which $6.7M was reported sold. Industry: Other.
Offering
- Filed: 2023-12-22
- Form: D
- Accession: 0001641226-23-000001
- Industry: Other
- Exemptions: 06b
- Total offering: $30.0M
- Amount sold: $6.7M
- Remaining: $23.3M
- Investors: 84
- Date of first sale: 2023-12-14
- Security types: equity, debt
- Revenue range: Decline to Disclose
- SEC file number: 021-500574
Issuer
- Name: OcuTerra Therapeutics, Inc.
- CIK: 0001641226
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 85 E. INDIA ROW, BOSTON, MA, 02110
- Phone: 339-234-1333
Officers, directors & promoters (20)
| Name | Role | Location |
|---|
| Kerrie Brady | Director | Boston, MA |
| Kerrie Brady | Executive Officer | Boston, MA |
| D. Scott Edwards | Executive Officer | Boston, MA |
| D. Scott Edwards | Promoter | Boston, MA |
| Robin H Steele | Director | Boston, MA |
| David J Tanzer | Executive Officer | Boston, MA |
| William H Koster | Director | Boston, MA |
| Bruce H Failing | Director | Boston, MA |
| Barbara H Ryan | Director | Boston, MA |
| Brenton Scott Saunders | Director | Boston, MA |
| Robert H Ruffolo | Director | Boston, MA |
| William Scott Steinkrauss | Executive Officer | Boston, MA |
| Robert H Dempsey | Director | Boston, MA |
| Kerrie H Brady | Director | Boston, MA |
| Kerrie H Brady | Executive Officer | Boston, MA |
| Brent H Saunders | Director | Boston, MA |
| David Scott Edwards | Executive Officer | Boston, MA |
| David Scott Edwards | Promoter | Boston, MA |
| Michael H Turner | Director | Boston, MA |
| Joseph H Pignato | Director | Boston, MA |
Other filings by this issuer (4)
More